| scholarly article | Q13442814 |
| P356 | DOI | 10.3171/JNS.2001.95.4.0651 |
| P698 | PubMed publication ID | 11596960 |
| P2093 | author name string | Nakamura H | |
| Kamiryo T | |||
| Ushio Y | |||
| Kochi M | |||
| Kuratsu J | |||
| Tada K | |||
| Hirano H | |||
| Shiraishi S | |||
| Saya H | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heterozygosity | Q124059385 |
| patient | Q181600 | ||
| P304 | page(s) | 651-659 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Journal of Neurosurgery | Q15708886 |
| P1476 | title | Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival | |
| P478 | volume | 95 |
| Q35800741 | Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials |
| Q26825496 | Biomarkers for glioma immunotherapy: the next generation |
| Q36539244 | Cancer stem cells from a rare form of glioblastoma multiforme involving the neurogenic ventricular wall |
| Q36107160 | Delivery systems and molecular targets of mechanism-based therapies for GBM. |
| Q35356484 | Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays. |
| Q35117832 | Genetic alterations of human brain tumors as molecular prognostic factors |
| Q36178870 | Growth, invasion, metastasis, differentiation, angiogenesis and apoptosis of gastric cancer regulated by expression of PTEN encoding products |
| Q51825686 | Homozygous 10q23/PTEN deletion and its impact on outcome in glioblastoma: a prospective translational study on a uniformly treated cohort of adult patients. |
| Q55473298 | Immunohistochemical markers for prognosis of anaplastic astrocytomas. |
| Q42289519 | Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy |
| Q48851931 | LOH on 10p14-p15 targets the PFKFB3 gene locus in human glioblastomas |
| Q48091842 | Loss of heterozygosity and uniparental disomy of chromosome region 10q23.3-26.3 in glioblastoma. |
| Q48317354 | Molecular Genetic Analysis of Anaplastic Pleomorphic Xanthoastrocytoma |
| Q55463675 | Molecular Pathogenesis of Malignant Glial Tumors |
| Q55471879 | Non-enhancing de novo glioblastoma: report of two cases. |
| Q36506366 | PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma |
| Q37139779 | PTEN in brain tumors |
| Q37270423 | PTEN signaling in brain: neuropathology and tumorigenesis. |
| Q34769937 | Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment |
| Q90175028 | Pleomorphic xanthoastrocytoma: a brief review |
| Q40642281 | Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002. |
| Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
| Q79095314 | Role of PTEN and MMP‐7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma |
| Q27853156 | The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide |
| Q55462856 | The hypermethylation of the O6-methylguanine-DNA methyltransferase gene promoter in gliomas--correlation with array comparative genome hybridization results and IDH1 mutation. |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
| Q30838145 | Treatment of glioblastoma in elderly patients. |
Search more.